Bausch Health Files 8-K: Other Events & Exhibits
Ticker: BHC · Form: 8-K · Filed: Mar 19, 2025 · CIK: 885590
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
Bausch Health filed an 8-K on 3/19/25 for other events and exhibits. Check for details.
AI Summary
On March 19, 2025, Bausch Health Companies Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided excerpt, but it serves as a notification of these items.
Why It Matters
This filing indicates that Bausch Health Companies Inc. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
- BIOVAIL CORP INTERNATIONAL (company) — Former Company Name
- March 19, 2025 (date) — Filing Date
FAQ
What specific "Other Events" are being reported by Bausch Health Companies Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported. It only lists the item category.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
When was this 8-K filing submitted to the SEC?
The filing was submitted on March 19, 2025.
What is the principal executive office address for Bausch Health Companies Inc.?
The principal executive office is located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
Has Bausch Health Companies Inc. undergone previous name changes?
Yes, the company was formerly known as Valeant Pharmaceuticals International, Inc. (name change effective September 28, 2010) and prior to that, BIOVAIL Corp and BIOVAIL CORP INTERNATIONAL.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Bausch Health Companies Inc. (BHC).